Trial intelligence / Profile preview

Olopatadine vs Fluticasone in Allergic Conjunctivitis

NCT00655109Phase 4Completed

Start
Feb 2008
Primary completion
Mar 2008
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of olopatadine, fluticasone propionate 0.05% cream in allergic conjunctivitis (AC). Started Feb 2008; status: completed.

02

Drugs

olopatadinefluticasone propionate 0.05% cream
03

Conditions

allergic conjunctivitis (AC)

Beyond the preview

Go deeper on NCT00655109.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00655109.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call